Gland Pharma shares plunge 12% today: Should you buy, hold or sell?

Kotak said the near-term outlook for Gland Pharma is sluggish but the product pipeline and entry into new markets provide medium-term growth visibility.

Related Keywords

China ,Nirmal ,Andhra Pradesh ,India ,Udayan Mukherjee ,Motilal Oswal , ,Gland Pharma ,Nirmal Bang Institutional ,Institutional Equities ,Indus Towers ,Tata Chemicals ,Hero Motocorp ,Gland Pharma Shares ,Gland Pharma Stock Price ,Gland Pharma Share Price ,Gland Pharma Q2 Results ,Gland Pharma Q2 Earnings ,Land Pharma Earnings ,Land Pharma Results ,Gland Pharma Profit ,Gland Pharma Share Price Today ,